Loading stock data…
$615.82+5.93 (+0.97%)
Medpace Holdings, Inc.
Medpace Holdings, Inc. in the Healthcare sector is trading at $615.89 with a market capitalization of $16.1B. Wall Street consensus targets $595.92 (13 analysts), implying a -3.2% move over the next 12 months. The stock is currently 9% below its 52-week high of $677.90, remaining 17.2% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $707.33M↑ | $706.60M↓ | $708.45M↑ | $659.90M↑ | $603.31M |
| Gross Profit | $201.64M↑ | $196.33M↓ | $205.32M↑ | $196.94M↑ | $180.01M |
| Operating Income | $146.82M↑ | $141.50M↓ | $153.27M↑ | $141.81M↑ | $126.33M |
| Net Income | $121.36M↓ | $123.87M↓ | $135.13M↑ | $111.14M↑ | $90.26M |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development proc...